CE-IVD marked kits CLART COVID-19 and qCOVID-19
GENOMICA S.A.U is proud to announce the CE-IVD approval of our 2 kits: CLART® COVID-19 and qCOVID-19 (Real Time PCR) after carrying out a satisfactory clinical validation with SARS-CoV-2 positive samples at Spanish National Reference Institute
More information
NEW BORDERS IN DIAGNOSIS AND GENETIC ANALYSIS
A bet for quality

MORE THAN 25 YEARS AT THE SERVICE OF MOLECULAR DIAGNOSIS AND GENETIC IDENTIFICATION

GENOMICA  is the first Spanish company  in Molecular Diagnostics and highly experienced in the analysis of genetic identification. Founded in 1990, with facilities in Madrid, GENOMICA is 100% owned by PharmaMar. It is our mission to improve the present molecular diagnostics tools and the human identification methods through reliability, automation and the highest quality standards.

Our main objective is to maintain leadership in genomics applications within the Spanish market, and to internationally extend our activities in the area of Molecular Diagnostics by means of the design, development, automation, and commercialization of new diagnostic applications of our innovative technological platform, Clinical Arrays Technology, CLART®.

GENOMICA has developed diagnostic tests for human papillomavirus associated with cervical cancer, the diagnosis of viral respiratory diseases, multiple detection of human herpes and enteroviruses, as well as detection of gene regions associated to the determination of human therapy response factors, in particular in the Oncology field.

GENOMICA also provides analysis of DNA, Legal and Forensic Medicine, and Technology Transfer services.

CLART® TECHNOLOGY

NEDxA®

NEDxA®

LINKEDIN

ÚLTIMAS NOTICIAS

ARABHEALTH 2015

GENOMICA attended the last ARABHEALTH 2015 in Dubai, UAE, last 26-29 January. GENOMICA, that has achieved the total automation with the autoclart® device and is present in several screenings all around the world, is constantly increasing its presence in the Middle East region and, as every year, we took this opportunity to share our knowledge […]

GENOMICA and the Foundation for Excellence and Quality in Oncology announce a framework agreement for collaboration in Oncology

The partnership will seek to improve quality cancer care in Spain by encouraging research projects, optimized use of GENOMICA diagnostic kits, scientific and medical dissemination and training of oncology professionals. GENOMICA, has entered a broad collaboration agreement with the Foundation for Excellence and Quality in Oncology focused on improving cancer care by fostering research projects […]

GENOMICA presents its new device for HPV testing: NEDxA

On the occasion of MEDICA, one of the world biggest trade-fairs of the healthcare sector, GENOMICA presented NEDxA, a new in vitro diagnostics device for HPV testing. The Export Sales were at the booth performing demonstrations for the public, resulting in a success regarding the amount of excitement it generated. This is a milestone in […]

GENOMICA will attend to MEDICA 2017

The Spanish IVD company will return to Düsseldorf to one of the most important medical congresses in the world. With more than forty years of experience, this congress gathers annually 100,000 attendees from more than 70 countries. Last year it brought together 5,100 exhibitors who presented products related to medical electronics, diagnostics, hospital supplies, Clinical […]